Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biopsy
New biopsy study findings have been reported from La Sapienza University
September 30th, 2008
According to recent research from Rome, Italy, "To evaluate the accuracy of the TRIMprob in the diagnosis of prostate neoplasm. Consecutive patients referred for prostate biopsy were prospectively enrolled." "Patients had history taken, physical examination by digital rectal examination (DRE) of the prostate, assessment of total and free serum prostate-specific antigen (PSA) levels, prostate transrectal ultrasonography (TRUS), and TRIMprob test. Indications for prostate biopsy included one or more of the following conditions: total serum PSA levels of 4.0 ng/mL or more, free/total serum PSA ratio of 0.18 or less, positive results on DRE, and suspicious findings on TRUS....
Source: Cancer Weekly (2008-09-30)
|
